News

Recent studies show efficacy and safety for both lemborexant and ozanimod.

Analysis of the Framingham Heart Study indicates the rate of ICH in older patients has been on the rise and suggests anticoagulant use could have contributed to this increase.

Greg Cosgrove, MD, explains how the respiratory condition can be overlooked by patients and clinicians.

A new analysis examines impact of treatment adherence in more than 1.2 million patients.

Study investigators have completed what they call the most comprehensive characterization of elementary school-age concussions to date.

A new paper highlights the means by which child healthcare, a "human science," will rebound from the pandemic.

A new observational analysis from the University of Mississippi Medical Center is disputing the notion marijuana use increases stroke risk.

The most recent protests to police brutality, and the ensuing violence across cities and towns, sparked response from most national medical institutions—who for decades have sought to address disparities in care.

A new retrospective chart review is examining effectiveness of nitrous oxide during labor and potential predictors to conversion to other therapies.

Prior coronavirus outbreaks help assess the possible psychiatric dangers related to COVID-19.

A new Canadian Thoracic Society guidance sets recommendations for continued or halted use of inhaled steroids, nebulizers, biologics, and more.

High-potency cannabis use led to an increase in cannabis use frequency, as well as cannabis problems.

Investigators expect an increase in demand for mental health services for young people in the coming years.

New research from Nutrition Live Online 2020 is diving into the impact of high and low quality carbohydrates on diabetes risk.

Rituximab should be the gold-standard treatment.

In recent years, ustekinumab and tofacitinib have both been effective in treating ulcerative colitis.

An analysis of claims data from 2018 finds spending on diabetes-related supplies is greater than that of insulin, which accounts for nearly 20% of out-of-pocket healthcare spending.

Despite normally being associated with end of life care, new research suggest palliative care could benefit heart failure patients.

The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Guidelines are needed to better understand who needs the test.

A new systematic review and meta-analysis is shedding light on the potential impact of inadequate health literacy on mortality and hospitalizations in heart failure patients.

Healthcare professionals can use technology to promote, educate, and support women who breastfeed.

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

Younger patients with sickle cell disease report more positive experiences in the emergency department than older patients.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

A Q&A with Anne Fung, MD, Global Development Lead for the Port Delivery System with ranibizumab at Genentech.

Currently, the use of minocycline is limited orally due to some systemic side effects.